Norris Financial Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-22,516
Closed -$26.8K 81
2022
Q3
$26.8K Sell
22,516
-495
-2% -$772 0.02% 65
2022
Q2
$41.4K Buy
23,011
+2,065
+10% +$3.05K 0.03% 64
2022
Q1
$42.3K Sell
20,946
-880
-4% -$1.73K 0.03% 82
2021
Q4
$59.1K Sell
21,826
-8,551
-28% -$31.6K 0.04% 83
2021
Q3
$135K Buy
30,377
+7,553
+33% +$36.4K 0.09% 80
2021
Q2
$132K Buy
22,824
+9,751
+75% +$57.1K 0.09% 80
2021
Q1
$91.8K Buy
+13,073
New +$87.7K 0.07% 76
2020
Q3
Sell
-13,048
Closed -$88.1K 88
2020
Q2
$88.1K Sell
13,048
-2,412
-16% -$18.3K 0.08% 60
2020
Q1
$98.3K Buy
+15,460
New +$124K 0.11% 58

Other funds holding CLVS